| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| anagrelide | cgmp-inhibited 3',5'-cyclic phosphodiesterase a | small molecule | NA | drugbank , DGIDB | Thrombocytosis[MeSHID:D013922] Hemorrhage[MeSHID:D006470] Neoplasm Metastasis[MeSHID:D009362] Thrombosis[MeSHID:D013927] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Thrombocythemia Essential[MeSHID:D013920] |
19.37 | approved | inhibitor |
| anagrelide | phosphodiesterase 3a | NA | Successful target | TTD , DGIDB | Thrombocytosis[MeSHID:D013922] Hemorrhage[MeSHID:D006470] Neoplasm Metastasis[MeSHID:D009362] Thrombosis[MeSHID:D013927] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Thrombocythemia Essential[MeSHID:D013920] |
19.37 | approved | unknown |
| anagrelide | phosphodiesterase 3a | NA | Successful target | TTD , DGIDB | Thrombocytosis[MeSHID:D013922] Hemorrhage[MeSHID:D006470] Neoplasm Metastasis[MeSHID:D009362] Thrombosis[MeSHID:D013927] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Thrombocythemia Essential[MeSHID:D013920] |
19.37 | approved | inhibitor |
| click here to return to the previous page | ||||||||